The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat.
about
Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.Effect of electroacupuncture on visceral hyperalgesia, serotonin and fos expression in an animal model of irritable bowel syndrome.Activation of submucosal 5-HT(3) receptors elicits a somatostatin-dependent inhibition of ion secretion in rat colonA randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea.Review article: intestinal serotonin signalling in irritable bowel syndrome.Alosetron and irritable bowel syndrome.Serotonergic modulation of visceral sensation: lower gut.Role of serotonin in the pathophysiology of the irritable bowel syndrome.The role of experimental models in developing new treatments for irritable bowel syndrome.Review article: visceral hypersensitivity.Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.Visceral pain: the neurophysiological mechanismPharmacology of serotonin: what a clinician should know.Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets.Diagnosis and therapy of irritable bowel syndrome.Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies.Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence.Brain-Gut Interactions in IBSAdenosine 5'-triphosphate and its relationship with other mediators that activate pelvic nerve afferent neurons in the rat colorectum.Pharmacogenomics and functional gastrointestinal disorders.5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cellsSerotonin receptor modulators in the treatment of irritable bowel syndrome.Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome.Studying the brain-gut axis with pharmacological imaging.Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome.Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.Administration of Wasabia koreana Ameliorates Irritable Bowel Syndrome-Like Symptoms in a Zymosan-Induced Mouse Model.Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials.5-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodium-induced murine colitis.Sensitization of visceral afferents to bradykinin in rat jejunum in vitro.Analgesic activity of cynaropicrinon on post-inflammatory irritable bowel syndrome visceral hypersensitivity in a rat model.Neuropathophysiology of functional gastrointestinal disorders.Visceral analgesic effect of 5-HT(4) receptor agonist in rats involves the rostroventral medulla (RVM).Effect of alosetron on left colonic motility in non-constipated patients with irritable bowel syndrome and healthy volunteers.Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans.Effect of granisetron on radiation-induced alterations of colonic motility and fluid absorption in rats.The relationship between propagated contractions and pseudoaffective changes in blood pressure in response to intestinal distension.The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients.Excitation of rat colonic afferent fibres by 5-HT(3) receptors.
P2860
Q33724343-C4702BF5-81B3-4B0F-B596-BDF2FC878674Q34028451-8D482808-EC6E-42DA-B550-857076A6ED48Q34078750-8EF81244-07D6-4138-AF85-52B4B47F6993Q34237231-80D02CA2-5394-4056-A008-048A60DC7CFCQ34566461-00FA46D3-CDED-4A86-B845-1E139A9A944FQ34649076-3F3DE41D-7924-4F09-8D08-7460ECBACB32Q34699859-38A8AD54-152F-4D0A-84D0-46D2AC3AD033Q35047066-AF56845C-B078-4658-B874-B086A8FE1B7DQ35071310-965D57A7-D472-47F7-BE78-CD6F89762FA3Q35086847-E41B8D74-6E10-4154-8432-22E58AF9A780Q35087100-45FB83F7-A4B5-4E5E-A179-3EEF1288EC27Q35164413-270B6CDD-3DD5-42AB-BF97-4DD875C9DAC9Q35596862-183C718C-2018-4BFA-815E-7B364065BF78Q35753361-1A27F1CC-96B8-4C75-B3B7-24AD898B8C8FQ35873847-0FFC6D8D-9627-4B55-B9C4-49AF03D319E8Q35985391-63F065D0-07BD-4F97-862B-E3F503CFC58AQ36072575-E65D0FA5-70AC-40B0-8A1D-F132E82096DAQ36076024-7BF92EE7-3293-44E6-9E31-EBF37C64D711Q36182806-C9151AF5-E06B-4C71-A8A1-F40AC53C208DQ36192802-B0395D0A-8296-4CC1-8FC5-7872539E7E63Q36681766-539DF62D-69D2-440A-A9E0-A71E9E7014A7Q36822923-4CCACD91-04D8-4AD9-9A57-A854A9C0AAE5Q36983944-C92C6559-2879-4974-8AA4-65D71107A7B4Q37057059-4B9CB458-7C14-41A9-A867-6DB14AE07D01Q37280264-9CC98D64-5B09-4C7B-B003-A7823662C285Q37871421-C3A48054-8E92-49A9-8F71-74EAB6CCA791Q38178543-B0FC35A5-6BF1-4E82-A230-4B497B0ABCE5Q38815136-EDD03BA6-D8B1-422D-9459-6301F958FCC3Q39397861-733E5974-5897-4128-948F-13430D88DC19Q42244233-B6A900ED-C47F-477E-9FEA-C03B96B3777AQ42480612-B1728509-DDB1-4E72-99B5-BEC6421825ABQ42675943-EA85D712-CCE6-4705-8DFB-E6AFEA603E6EQ42846456-B5610DBD-FAD6-4D90-9EFB-1B70C841A9FBQ43139081-BFC1AC72-032E-442A-AAD1-C40D7BECB5A4Q43352672-F5AD1027-922C-4E43-9F03-5B354A9F05E5Q43892498-8EF8A7F0-D6B8-43BE-909D-6ADA9DC1F291Q43904309-C9D4F951-D596-4480-8E5B-267F0FB235ABQ43923615-241D354A-57EE-416D-B32A-F901D9AA5D5AQ44080562-BCDFBE0D-1845-4A8A-B712-520479067190Q44201747-7EEF925F-4F07-4A96-93A1-E2BF1573F781
P2860
The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The 5-HT(3) receptor antagonis ...... sion in the anaesthetised rat.
@ast
The 5-HT(3) receptor antagonis ...... sion in the anaesthetised rat.
@en
type
label
The 5-HT(3) receptor antagonis ...... sion in the anaesthetised rat.
@ast
The 5-HT(3) receptor antagonis ...... sion in the anaesthetised rat.
@en
prefLabel
The 5-HT(3) receptor antagonis ...... sion in the anaesthetised rat.
@ast
The 5-HT(3) receptor antagonis ...... sion in the anaesthetised rat.
@en
P2093
P2860
P356
P1433
P1476
The 5-HT(3) receptor antagonis ...... sion in the anaesthetised rat.
@en
P2093
Boissonade FM
Kozlowski CM
P2860
P304
P356
10.1136/GUT.46.4.474
P407
P577
2000-04-01T00:00:00Z